期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

宫颈癌盆腔复发调强放疗17例临床观察 被引量：3

下载PDF
导出
摘要 宫颈癌是最常见的女性生殖系统恶性肿瘤之一。在世界范围内，每年新发宫颈浸润癌47万例，另有23万患者死于宫颈浸润癌。即使经过根治性手术治疗或放疗，仍有35％的宫颈癌患者复发，其中盆腔复发占60％以上。宫颈癌的盆腔复发治疗十分困难，治疗手段有限，预后极差，5年生存率仅为0%～30％，平均存活期为7个月，中位生存期仅为5～18个月。无论初次治疗的方法是手术还是常规放疗，
作者 申明霞 古丽娜.库尔班
机构地区 新疆医科大学附属肿瘤医院妇二科
出处 《新疆医学》 2007年第6期88-91,共4页 Xinjiang Medical Journal
关键词 盆腔复发 调强放疗 宫颈癌 临床观察 根治性手术治疗 生殖系统恶性肿瘤 宫颈浸润癌 中位生存期
分类号 R735.37 [医药卫生—肿瘤] R730.55 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Amdrawis M Cervical Vaccines available in 2007,Drug Discoy Today,2005,10 (14):949-950.
  • 2Philip J.Disaia,William T.Creasman Clinical Gynecologic Oncology.sixth edition.Health Science Asia,Elsevier Science,2002:90.
  • 3李孟达.宫颈复发癌的诊断和治疗[J].实用妇产科杂志,1994,10(5):242-244. 被引量：15
  • 4连利娟,林巧雅.妇科肿瘤学.第3版.北京:人民卫生出版社,2000.311-316.
  • 5Ya makawa Y,Fujimuram,Hidaka T,et al.Neoadjuvant intraartorial infusion chemotherapy in patients with cervical cancer.Gynecol On2 col,2000,(7):264-270.
  • 6Souhamil,GiLRA,Allan SE,et al.Arandom ized trial of chemotherapy followed by pelvic rodwiom theraroy in stage ⅢB carciroma of the cervix.J din orcd,1991,(7):970-977.
  • 7Maneo A,Landoni F,Cormio G et al.Radical hysterctomy for recurrent or persistent cervical cancer following radiation therapy.Int J Gynecol Cancer 1999;9:295-301.
  • 8Moorc DH,Blessing JA,McQucllon RP,et al.Phase Ⅲ study of cisplatin with or without Paclitaxel in stage ⅣB,recurrent,or persistet squamous cell carcinoma of the cervix:A Gynecologic Oncology Group study.J Clin Oncol,2004,22(15):3113-3119.
  • 9Paley PJ,Goff BA,Mllnudri R,et al The prognostic signifieanee of radiation dose and residual tumor in the treatmentof barrel-shaped ndophytic cervical carcinoma.Gynecol Oncol,2000,76:373-379.
  • 10Wang CH,Lai CH,Huang HJ,et al.Recuurent cervical carcinoma after primary radical surgery.Am J Obstet Gynecol,1999,181(3):518-524.

二级参考文献10

  • 1Hong JH,Tsai CS,Lai CH,et al.Recurrent squamous cell carcinoma of cervix after definitive radiotherapy[J].Int J Radiat Oncol Biol Phys,2004,60(1):249～257.
  • 2Wang CH,Lai CH,Huang HJ,et al.Recuurent cervical carcinoma after primary radical surgery[J].Am J Obstet Gynecol,1999,181 (3):518～ 524.
  • 3Grigsby PW,Vest ML,Perez CA.Recurrent carcinoma of the cervix exclusively in the paraaortic nodes following radiation therapy[J].Int J Radiat Oncol Biol Phys,1994,28(2):451～455.
  • 4Singh AK,Grigsby PW,Rader JS,et al.Cervix carcinoma,concurrent chemoradiotherapy,and salvge of isolated paraaortic lymph node recurrence[J].Int J Radiat Oncol Biol Phys,2005,61(2):450～455.
  • 5Moore DH,BlessingJA,McQuellon RP,et al.Phase Ⅲ study of cisplatin with or without Paclitaxel in stage IVB,recurrent,or persistent squamous cell carcinoma of the cervix:A Gynecologic Oncology Group study[J].J Clin Oncol,2004,22(15):3113～3119.
  • 6Tsuda H,Hashiguchi Y,Nishimura S,et al.Phase Ⅰ-Ⅱ study of irinotecan (CPT-Ⅱ) plus nedaplatin (254-S) with recombinat human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer[J].Br J Cancer,2004,91(6):1032～1037.
  • 7Portelance L,Chaoks,Grigsby PW,et al.Intensity modulated radiation therapy (IMRT) reduces small bowel,rectum,and bladder doses in patients with cervical cancer receiving pelvic and paraortic irradiation[J].Int J Radiat Oncol Biol Phys,2001,51(1):261～266.
  • 8Roeske JC,Lujan A,Rotmensch J,et al.Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies[J].Int J Radiat Oncol Biol Phys,2000,48(5):1613 ～ 1621.
  • 9Ahmed PS,Kim RY,Duan J,et al.IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk[J].Int J Radiat Oncol Biol Phys,2004,60(2):505 ～512.
  • 10蒋国梁.三维适形放疗和调强放疗[J].肿瘤,2003,23(4):261-262. 被引量：20

共引文献39

同被引文献23

引证文献3

二级引证文献12

新疆医学
2007年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部